Avid Bioservices Inc (CDMO)

[biopharm]

I agree and how many were paid to roll over ?

Ambit Biosciences and others....among the dozens of collaborators had some incentive it seems to break ties with PS Targeting research but that research now playing a key role in Biomarkers

Daiichi Sankyo bought out Ambit Biosciences just mere weeks after it was pointed out about employee Troy Sklenar working with Peregrine and listed as employed with Ambit Biosciences and the pipeline of Ambit had CSF1R ...

What did Daiichi Sankyo find out ...
https://www.ncbi.nlm.nih.gov/medgen/1392528

Negative charge surface receptors and the reduction in MDSCs ..etc all led to the Biomarkers / study of protein pathways

Biomarkers are #1 priority that Oncologie is using and if they are working with Precision for Medicine (that bought out Epiontis) where both were building Biomarker databases then the current BOD had failed their Fiduciary Duties since they gave no more disclosures regarding the IP

Obviously, the new BODs were directed to vote on this deal in exchange for ....hmmmm